

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.96506475 |
| 2 | regulation of fibrinolysis (GO:0051917) | 5.91885705 |
| 3 | regulation of protein activation cascade (GO:2000257) | 5.67819018 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 5.67312453 |
| 5 | regulation of complement activation (GO:0030449) | 5.59584809 |
| 6 | low-density lipoprotein particle remodeling (GO:0034374) | 5.49812962 |
| 7 | plasma lipoprotein particle assembly (GO:0034377) | 5.40938482 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.28097916 |
| 9 | protein carboxylation (GO:0018214) | 5.28097916 |
| 10 | protein-lipid complex assembly (GO:0065005) | 4.88026629 |
| 11 | negative regulation of protein activation cascade (GO:2000258) | 4.81222771 |
| 12 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76428437 |
| 13 | protein-lipid complex remodeling (GO:0034368) | 4.76428437 |
| 14 | macromolecular complex remodeling (GO:0034367) | 4.76428437 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 4.73693758 |
| 16 | cholesterol efflux (GO:0033344) | 4.73626200 |
| 17 | regulation of cholesterol esterification (GO:0010872) | 4.66014849 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 4.61595276 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.61595276 |
| 20 | plasma lipoprotein particle organization (GO:0071827) | 4.49014529 |
| 21 | complement activation, alternative pathway (GO:0006957) | 4.48637610 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.42664433 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 4.42664433 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.33309890 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 4.27176182 |
| 26 | negative regulation of complement activation (GO:0045916) | 4.26885099 |
| 27 | protein-lipid complex subunit organization (GO:0071825) | 4.25724667 |
| 28 | regulation of bile acid biosynthetic process (GO:0070857) | 4.15382080 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.14391436 |
| 30 | plasma lipoprotein particle clearance (GO:0034381) | 4.09090794 |
| 31 | intestinal absorption (GO:0050892) | 4.06649687 |
| 32 | regulation of cholesterol homeostasis (GO:2000188) | 4.06003844 |
| 33 | low-density lipoprotein particle clearance (GO:0034383) | 3.90991363 |
| 34 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.90803026 |
| 35 | regulation of extracellular matrix disassembly (GO:0010715) | 3.90061244 |
| 36 | regulation of apoptotic cell clearance (GO:2000425) | 3.88649478 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.74589497 |
| 38 | COPII vesicle coating (GO:0048208) | 3.67694313 |
| 39 | complement activation, classical pathway (GO:0006958) | 3.64766223 |
| 40 | lipoprotein transport (GO:0042953) | 3.62357358 |
| 41 | lipoprotein metabolic process (GO:0042157) | 3.56430631 |
| 42 | protein activation cascade (GO:0072376) | 3.54078765 |
| 43 | phospholipid efflux (GO:0033700) | 3.43607876 |
| 44 | ethanol oxidation (GO:0006069) | 3.41344666 |
| 45 | acute-phase response (GO:0006953) | 3.39056208 |
| 46 | negative regulation of humoral immune response (GO:0002921) | 3.37476991 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 3.36346730 |
| 48 | negative regulation of sterol transport (GO:0032372) | 3.36346730 |
| 49 | regulation of plasminogen activation (GO:0010755) | 3.35417413 |
| 50 | acylglycerol homeostasis (GO:0055090) | 3.33075967 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.33075967 |
| 52 | regulation of humoral immune response (GO:0002920) | 3.31686648 |
| 53 | positive regulation of steroid metabolic process (GO:0045940) | 3.31020028 |
| 54 | cholesterol transport (GO:0030301) | 3.30297177 |
| 55 | sterol transport (GO:0015918) | 3.30297177 |
| 56 | positive regulation of blood coagulation (GO:0030194) | 3.26229193 |
| 57 | positive regulation of hemostasis (GO:1900048) | 3.26229193 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 3.22625528 |
| 59 | oligosaccharide catabolic process (GO:0009313) | 3.22014381 |
| 60 | angiotensin maturation (GO:0002003) | 3.19675061 |
| 61 | positive regulation of coagulation (GO:0050820) | 3.18109841 |
| 62 | complement activation (GO:0006956) | 3.16134455 |
| 63 | glutamate metabolic process (GO:0006536) | 3.11462613 |
| 64 | cholesterol homeostasis (GO:0042632) | 3.10920155 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.08614637 |
| 66 | epoxygenase P450 pathway (GO:0019373) | 3.08431647 |
| 67 | sterol homeostasis (GO:0055092) | 3.07867959 |
| 68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.97888830 |
| 69 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.97888830 |
| 70 | negative regulation of hemostasis (GO:1900047) | 2.94795347 |
| 71 | negative regulation of blood coagulation (GO:0030195) | 2.94795347 |
| 72 | cellular zinc ion homeostasis (GO:0006882) | 2.93113187 |
| 73 | cellular response to ethanol (GO:0071361) | 2.91421064 |
| 74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90838248 |
| 75 | regulation of extracellular matrix organization (GO:1903053) | 2.90712944 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.90220061 |
| 77 | fibrinolysis (GO:0042730) | 2.84058139 |
| 78 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.83976411 |
| 79 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.80511622 |
| 80 | lipid homeostasis (GO:0055088) | 2.78094506 |
| 81 | positive regulation of extracellular matrix organization (GO:1903055) | 2.76399947 |
| 82 | peptide hormone processing (GO:0016486) | 2.75142809 |
| 83 | cellular glucuronidation (GO:0052695) | 2.74652752 |
| 84 | regulation of cholesterol storage (GO:0010885) | 2.74370204 |
| 85 | aromatic amino acid family catabolic process (GO:0009074) | 2.73262563 |
| 86 | negative regulation of coagulation (GO:0050819) | 2.71331891 |
| 87 | regulation of cholesterol metabolic process (GO:0090181) | 2.69023607 |
| 88 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68355426 |
| 89 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.67304462 |
| 90 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.62694598 |
| 91 | neutral lipid catabolic process (GO:0046461) | 2.62282124 |
| 92 | acylglycerol catabolic process (GO:0046464) | 2.62282124 |
| 93 | ethanol metabolic process (GO:0006067) | 2.62265603 |
| 94 | negative regulation of wound healing (GO:0061045) | 2.61275584 |
| 95 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.60171408 |
| 96 | urea metabolic process (GO:0019627) | 2.53759891 |
| 97 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53493062 |
| 98 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.53343527 |
| 99 | negative regulation of fatty acid transport (GO:2000192) | 2.53294074 |
| 100 | fatty acid homeostasis (GO:0055089) | 2.50790924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.41477598 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27684620 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97038813 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.54343542 |
| 5 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.18315538 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.03858681 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.90026248 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83648707 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.78626929 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.73752621 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.61983203 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.52009401 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.50899606 |
| 14 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.21772987 |
| 15 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.17489529 |
| 16 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.15565521 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.14059447 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13790037 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09032618 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07445414 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94620769 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92480827 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87384308 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86418843 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83597888 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74269317 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72316815 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71962325 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.67599248 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.58783193 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58044662 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.57892735 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56773933 |
| 34 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.56665339 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54145394 |
| 36 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.51934722 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51784561 |
| 38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51463395 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47927525 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47587275 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47408568 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46658022 |
| 43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39801375 |
| 44 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39478586 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38448967 |
| 46 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32303961 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32142383 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32021531 |
| 49 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31312596 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30938478 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30852068 |
| 52 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29194755 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27835484 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21577304 |
| 55 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19626499 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13976719 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04702008 |
| 58 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04047712 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03867504 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02252298 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02131543 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02131543 |
| 63 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01541670 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01307116 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97650028 |
| 66 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93831401 |
| 67 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92961063 |
| 68 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92310113 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91393667 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91098836 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.90956824 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90817192 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90259522 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89161871 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87746072 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87323149 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86848691 |
| 78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.86730622 |
| 79 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.86664310 |
| 80 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86194819 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85692297 |
| 82 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84548546 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84445415 |
| 84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.82897353 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81197319 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81014523 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79784784 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79775186 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79663528 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78273820 |
| 91 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78225772 |
| 92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77823445 |
| 93 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77805031 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.76718743 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.75828147 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75797982 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75773670 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75647671 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75138213 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74857073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.02423823 |
| 2 | MP0005365_abnormal_bile_salt | 4.04819957 |
| 3 | MP0003195_calcinosis | 3.81561029 |
| 4 | MP0005360_urolithiasis | 3.75247343 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.37257057 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.25528739 |
| 7 | MP0001666_abnormal_nutrient_absorption | 2.94137846 |
| 8 | MP0003252_abnormal_bile_duct | 2.73965502 |
| 9 | MP0003122_maternal_imprinting | 2.56384775 |
| 10 | MP0003868_abnormal_feces_composition | 2.38602408 |
| 11 | MP0009840_abnormal_foam_cell | 2.35664349 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.32177914 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.30056213 |
| 14 | MP0005451_abnormal_body_composition | 2.13468129 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.07345905 |
| 16 | MP0006054_spinal_hemorrhage | 2.04760197 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.01225317 |
| 18 | MP0002166_altered_tumor_susceptibility | 1.96493919 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87059507 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 1.84955479 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.79894544 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.79390509 |
| 23 | MP0005332_abnormal_amino_acid | 1.79109330 |
| 24 | MP0005379_endocrine/exocrine_gland_phen | 1.79028073 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.77238085 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.76536197 |
| 27 | MP0000609_abnormal_liver_physiology | 1.72169238 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.62845859 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.62302445 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.57428924 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.54410738 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.52789641 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.45290239 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.44697570 |
| 35 | MP0002971_abnormal_brown_adipose | 1.44693878 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.41312527 |
| 37 | MP0002132_abnormal_respiratory_system | 1.40865875 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.38421538 |
| 39 | MP0005408_hypopigmentation | 1.38035716 |
| 40 | MP0001661_extended_life_span | 1.30668042 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.30333343 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.30265821 |
| 43 | MP0005409_darkened_coat_color | 1.28503671 |
| 44 | MP0000604_amyloidosis | 1.27675069 |
| 45 | MP0001756_abnormal_urination | 1.26985683 |
| 46 | MP0001944_abnormal_pancreas_morphology | 1.24267466 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.23171338 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.19701779 |
| 49 | MP0001915_intracranial_hemorrhage | 1.12109159 |
| 50 | MP0002006_tumorigenesis | 1.10037410 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.09808394 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.08659215 |
| 53 | MP0000598_abnormal_liver_morphology | 1.07944514 |
| 54 | MP0009115_abnormal_fat_cell | 1.07437664 |
| 55 | MP0003303_peritoneal_inflammation | 1.03607577 |
| 56 | MP0003123_paternal_imprinting | 1.03515462 |
| 57 | MP0005164_abnormal_response_to | 1.01720286 |
| 58 | MP0005448_abnormal_energy_balance | 1.00406079 |
| 59 | MP0002009_preneoplasia | 0.98824329 |
| 60 | MP0000685_abnormal_immune_system | 0.98463315 |
| 61 | MP0008469_abnormal_protein_level | 0.97627804 |
| 62 | MP0009642_abnormal_blood_homeostasis | 0.97093985 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 0.96517301 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 0.95189344 |
| 65 | MP0003690_abnormal_glial_cell | 0.93468608 |
| 66 | MP0001764_abnormal_homeostasis | 0.91985862 |
| 67 | MP0001765_abnormal_ion_homeostasis | 0.90554116 |
| 68 | MP0003953_abnormal_hormone_level | 0.87313853 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.87175550 |
| 70 | MP0002933_joint_inflammation | 0.87158383 |
| 71 | MP0005670_abnormal_white_adipose | 0.86225507 |
| 72 | MP0005375_adipose_tissue_phenotype | 0.86156965 |
| 73 | MP0002396_abnormal_hematopoietic_system | 0.82537417 |
| 74 | MP0005666_abnormal_adipose_tissue | 0.82037715 |
| 75 | MP0004043_abnormal_pH_regulation | 0.80081034 |
| 76 | MP0003436_decreased_susceptibility_to | 0.79756039 |
| 77 | MP0003724_increased_susceptibility_to | 0.79223051 |
| 78 | MP0004883_abnormal_blood_vessel | 0.77416667 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.76183304 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.75757645 |
| 81 | MP0005535_abnormal_body_temperature | 0.75005500 |
| 82 | MP0006082_CNS_inflammation | 0.73632373 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71104073 |
| 84 | MP0001835_abnormal_antigen_presentation | 0.70729965 |
| 85 | MP0004272_abnormal_basement_membrane | 0.70164489 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.69032343 |
| 87 | MP0002168_other_aberrant_phenotype | 0.68996639 |
| 88 | MP0009697_abnormal_copulation | 0.68749240 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.68717613 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.66748547 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.65733206 |
| 92 | MP0009785_altered_susceptibility_to | 0.64091655 |
| 93 | MP0003329_amyloid_beta_deposits | 0.63047428 |
| 94 | MP0008004_abnormal_stomach_pH | 0.62908093 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.62683200 |
| 96 | MP0005334_abnormal_fat_pad | 0.61318908 |
| 97 | MP0003866_abnormal_defecation | 0.60701902 |
| 98 | MP0000249_abnormal_blood_vessel | 0.59339167 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.59054198 |
| 100 | MP0002970_abnormal_white_adipose | 0.58926858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.78897679 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.78469456 |
| 3 | Complement deficiency (HP:0004431) | 5.43657999 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.32317786 |
| 5 | Abnormality of the common coagulation pathway (HP:0010990) | 4.83528004 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55579607 |
| 7 | Joint hemorrhage (HP:0005261) | 4.54250328 |
| 8 | Abnormality of complement system (HP:0005339) | 4.31571652 |
| 9 | Xanthomatosis (HP:0000991) | 4.22424097 |
| 10 | Glomerulonephritis (HP:0000099) | 4.06061377 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.80089320 |
| 12 | Acanthocytosis (HP:0001927) | 3.76131051 |
| 13 | Gingival bleeding (HP:0000225) | 3.65547150 |
| 14 | Vascular calcification (HP:0004934) | 3.59434967 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.46464039 |
| 16 | Fat malabsorption (HP:0002630) | 3.37741222 |
| 17 | Cardiovascular calcification (HP:0011915) | 3.36820526 |
| 18 | Mitral stenosis (HP:0001718) | 3.24764198 |
| 19 | Hypercholesterolemia (HP:0003124) | 3.17254825 |
| 20 | Spontaneous abortion (HP:0005268) | 3.05732448 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.98416857 |
| 22 | Menorrhagia (HP:0000132) | 2.97307878 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.88949238 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.80208723 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.80208723 |
| 26 | Proximal tubulopathy (HP:0000114) | 2.80012458 |
| 27 | Skin nodule (HP:0200036) | 2.78029749 |
| 28 | Myocardial infarction (HP:0001658) | 2.74813578 |
| 29 | Epidermoid cyst (HP:0200040) | 2.74757364 |
| 30 | Hemorrhage of the eye (HP:0011885) | 2.72662670 |
| 31 | Hypoglycemic coma (HP:0001325) | 2.70728143 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66455877 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65603866 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65603866 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65603866 |
| 36 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.63902530 |
| 37 | Purpura (HP:0000979) | 2.59908697 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55556265 |
| 39 | Poikilocytosis (HP:0004447) | 2.55234605 |
| 40 | Asymmetry of the thorax (HP:0001555) | 2.51830732 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 2.43567061 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.39047651 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.37842579 |
| 44 | Orthostatic hypotension (HP:0001278) | 2.36073239 |
| 45 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.35522439 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.35522439 |
| 47 | Nephritis (HP:0000123) | 2.34396332 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.33494332 |
| 49 | Steatorrhea (HP:0002570) | 2.32824916 |
| 50 | Hyperglycemia (HP:0003074) | 2.31837120 |
| 51 | Abnormal tarsal ossification (HP:0008369) | 2.29424059 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.26856490 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23155778 |
| 54 | Facial shape deformation (HP:0011334) | 2.21511972 |
| 55 | Potter facies (HP:0002009) | 2.21511972 |
| 56 | Testicular neoplasm (HP:0010788) | 2.19194185 |
| 57 | Flat acetabular roof (HP:0003180) | 2.18806826 |
| 58 | Increased CSF protein (HP:0002922) | 2.17347267 |
| 59 | Polycythemia (HP:0001901) | 2.17134464 |
| 60 | Peritonitis (HP:0002586) | 2.16842960 |
| 61 | Hypotension (HP:0002615) | 2.16631463 |
| 62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16472941 |
| 63 | Pigmentary retinal degeneration (HP:0001146) | 2.15759247 |
| 64 | Epistaxis (HP:0000421) | 2.15418845 |
| 65 | Rickets (HP:0002748) | 2.15142923 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.10828094 |
| 67 | Thrombophlebitis (HP:0004418) | 2.09994891 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.08626357 |
| 69 | Osteomalacia (HP:0002749) | 2.08472036 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.08368463 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.08368463 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.07758788 |
| 73 | Hypophosphatemic rickets (HP:0004912) | 2.06033886 |
| 74 | Joint swelling (HP:0001386) | 2.05620909 |
| 75 | Episodic fever (HP:0001954) | 2.03858909 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.02289296 |
| 77 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98034263 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 1.97439491 |
| 79 | Amyloidosis (HP:0011034) | 1.96422002 |
| 80 | Hypothermia (HP:0002045) | 1.96216290 |
| 81 | Abnormality of vitamin metabolism (HP:0100508) | 1.90145203 |
| 82 | Ovoid vertebral bodies (HP:0003300) | 1.89646371 |
| 83 | Abnormality of the lumbar spine (HP:0100712) | 1.89137668 |
| 84 | Arthropathy (HP:0003040) | 1.88849663 |
| 85 | Late onset (HP:0003584) | 1.87475732 |
| 86 | Striae distensae (HP:0001065) | 1.86153032 |
| 87 | Ketoacidosis (HP:0001993) | 1.82052880 |
| 88 | Pulmonary embolism (HP:0002204) | 1.81465883 |
| 89 | Papillary thyroid carcinoma (HP:0002895) | 1.80835144 |
| 90 | Broad palm (HP:0001169) | 1.78458163 |
| 91 | Abnormal foot bone ossification (HP:0010675) | 1.78314405 |
| 92 | Hypoalphalipoproteinemia (HP:0003233) | 1.74787847 |
| 93 | Broad alveolar ridges (HP:0000187) | 1.70644263 |
| 94 | Glycosuria (HP:0003076) | 1.70428763 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 1.70428763 |
| 96 | Coarse hair (HP:0002208) | 1.67558131 |
| 97 | Hypophosphatemia (HP:0002148) | 1.65932862 |
| 98 | Overlapping toe (HP:0001845) | 1.64158772 |
| 99 | Flared iliac wings (HP:0002869) | 1.62534099 |
| 100 | Small epiphyses (HP:0010585) | 1.62479523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR3 | 4.66246469 |
| 2 | FGFR4 | 4.31939877 |
| 3 | ERN1 | 2.84184620 |
| 4 | MAP3K2 | 2.47551362 |
| 5 | FRK | 2.41381353 |
| 6 | TRPM7 | 2.06594769 |
| 7 | AKT3 | 2.03320565 |
| 8 | ICK | 1.81785909 |
| 9 | ACVR1B | 1.80739156 |
| 10 | MAP2K3 | 1.75975015 |
| 11 | FGFR2 | 1.72963674 |
| 12 | WNK4 | 1.72683572 |
| 13 | PIK3CG | 1.62745493 |
| 14 | CDK12 | 1.60059360 |
| 15 | WNK1 | 1.58454946 |
| 16 | TYK2 | 1.57505576 |
| 17 | PRKAA2 | 1.56253264 |
| 18 | MAP3K1 | 1.53500827 |
| 19 | NLK | 1.53456486 |
| 20 | EEF2K | 1.45802501 |
| 21 | RET | 1.42833620 |
| 22 | PKN2 | 1.41554030 |
| 23 | BMPR2 | 1.37551917 |
| 24 | MAP3K14 | 1.32431977 |
| 25 | JAK1 | 1.31296091 |
| 26 | SCYL2 | 1.29363862 |
| 27 | PDPK1 | 1.29360599 |
| 28 | EPHA3 | 1.29308618 |
| 29 | KSR2 | 1.25837797 |
| 30 | RIPK1 | 1.25185161 |
| 31 | STK3 | 1.23186596 |
| 32 | MAP3K13 | 1.20545261 |
| 33 | RIPK4 | 1.19312539 |
| 34 | PIK3CA | 1.19220761 |
| 35 | MAPK11 | 1.19096366 |
| 36 | EIF2AK3 | 1.17860806 |
| 37 | EIF2AK1 | 1.14917048 |
| 38 | PDK1 | 1.12994740 |
| 39 | PDGFRA | 1.11308367 |
| 40 | TGFBR2 | 1.10285114 |
| 41 | MAP2K6 | 1.06048026 |
| 42 | SGK3 | 1.02444190 |
| 43 | STK24 | 1.00304716 |
| 44 | TRIB3 | 1.00278178 |
| 45 | STK39 | 0.98695771 |
| 46 | LATS1 | 0.98159628 |
| 47 | MAP3K6 | 0.97614118 |
| 48 | HIPK2 | 0.97133868 |
| 49 | PRPF4B | 0.96844183 |
| 50 | SGK2 | 0.93488720 |
| 51 | FGFR1 | 0.90841050 |
| 52 | IRAK3 | 0.89482079 |
| 53 | YES1 | 0.88322559 |
| 54 | CDK6 | 0.85418374 |
| 55 | CDC42BPA | 0.85160183 |
| 56 | CSF1R | 0.84468711 |
| 57 | JAK2 | 0.83168572 |
| 58 | IRAK1 | 0.78953310 |
| 59 | PRKG2 | 0.78556914 |
| 60 | NTRK3 | 0.78313980 |
| 61 | FER | 0.78111528 |
| 62 | DDR2 | 0.75798921 |
| 63 | JAK3 | 0.75450466 |
| 64 | RPS6KB1 | 0.74910640 |
| 65 | STK4 | 0.74067942 |
| 66 | ZAP70 | 0.71368668 |
| 67 | KIT | 0.70699115 |
| 68 | NEK9 | 0.68486978 |
| 69 | FGR | 0.68053800 |
| 70 | MST4 | 0.65385609 |
| 71 | FLT3 | 0.61848207 |
| 72 | ITK | 0.61473211 |
| 73 | SGK1 | 0.60815614 |
| 74 | TBK1 | 0.60639671 |
| 75 | SGK223 | 0.59031837 |
| 76 | SGK494 | 0.59031837 |
| 77 | SYK | 0.58191446 |
| 78 | PRKAA1 | 0.56932022 |
| 79 | MAPKAPK3 | 0.56410814 |
| 80 | MATK | 0.56067166 |
| 81 | EPHB1 | 0.52918392 |
| 82 | BRD4 | 0.52626150 |
| 83 | BRSK2 | 0.49258480 |
| 84 | MAP3K7 | 0.48748578 |
| 85 | PTK6 | 0.48469920 |
| 86 | MAP3K3 | 0.47132013 |
| 87 | MAP3K5 | 0.45627322 |
| 88 | MAP3K9 | 0.44991340 |
| 89 | GRK6 | 0.44862679 |
| 90 | TAOK3 | 0.44013753 |
| 91 | GSK3A | 0.43385577 |
| 92 | ERBB2 | 0.42644207 |
| 93 | DAPK2 | 0.42083097 |
| 94 | PRKACG | 0.40892341 |
| 95 | IKBKE | 0.40839035 |
| 96 | MAP3K12 | 0.39374073 |
| 97 | MAP2K4 | 0.39259640 |
| 98 | SIK1 | 0.37544095 |
| 99 | LYN | 0.36656438 |
| 100 | BLK | 0.36356272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.42357687 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.73482626 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52809760 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50600846 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.46929150 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25804451 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11683340 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06062650 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05588394 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95010311 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.83174983 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.81606974 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78786777 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74887494 |
| 15 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74691963 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73638714 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.72567216 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70678023 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.70517291 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.64339544 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64178519 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63645902 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60069543 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60044051 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.55708359 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46158295 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37269846 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35233458 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34334626 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33410092 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32318334 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.28610269 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28557362 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.24297306 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22638758 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22233061 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20027342 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17991297 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04285582 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95244599 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 0.94163882 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 0.92737687 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91393463 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89574522 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89557095 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86787457 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 0.85876897 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.85384042 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76554263 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76434655 |
| 51 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76091929 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72808396 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.72631128 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67390506 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65947558 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64590962 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64371818 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64334273 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.62739440 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59447778 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57741589 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57411988 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55619095 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54783362 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54716566 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54635382 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54258565 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51966770 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51693336 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48648107 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48422689 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47767257 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47535424 |
| 74 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46902696 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45778080 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.45574668 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45349256 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.42315294 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42188024 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41619414 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40035897 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39338250 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38945358 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38914679 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.36184310 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36112404 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34965593 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32397136 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.31840238 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28927284 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28213890 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26712899 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25176748 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23979305 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23894946 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22178837 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.21933839 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.19327588 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19273207 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18976201 |

